Gilead

Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercialises innovative medicines in areas of unmet medical need. Founded in 1987, Gilead has a strong commitment to advancing the care of patients with life-threatening diseases, particularly in the fields of HIV/AIDS, liver diseases, cancer, inflammatory diseases, and respiratory diseases.

The company’s mission is to transform the lives of people by providing them with access to high-quality medicines. Gilead’s research and development efforts are focused on creating therapies that improve patient outcomes and enhance their quality of life.

• Innovative Research: Gilead invests heavily in research to discover new treatments and improve existing therapies.
• Global Reach: With operations in over 35 countries, Gilead aims to make its medicines accessible to patients worldwide.
• Patient-Centric Approach: The company prioritises patient needs and works closely with healthcare providers to ensure effective treatment solutions.
• Commitment to Sustainability: Gilead is dedicated to corporate social responsibility, focusing on environmental sustainability and community engagement.

Gilead’s portfolio includes several groundbreaking therapies that have changed the landscape of treatment for various diseases. The company continues to explore new avenues for growth through strategic partnerships and collaborations with other organisations in the healthcare sector.

Headquartered in Foster City, California, Gilead operates with a workforce of approximately 10,000 employees globally. The company’s vision is to be a leader in the biopharmaceutical industry, driving innovation and improving health outcomes for patients around the world.